Kallikrein 15 Antibody (05) [DyLight 550]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-26080R
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 05
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Kallikrein 15 Antibody (05) [DyLight 550]
Immunogen
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human Kallikrein 15 (Accession#: NP_059979.2; Met1-Asn256).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Kallikrein 15 Antibody (05) [DyLight 550]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Kallikrein 15
Alternate Names
ACO, KLK15, Prostinogen
Gene Symbol
KLK15
Additional Kallikrein 15 Products
Product Documents for Kallikrein 15 Antibody (05) [DyLight 550]
Product Specific Notices for Kallikrein 15 Antibody (05) [DyLight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...